FIKK1

FIKK1 (PF3D7_0102600) is an exported serine/threonine kinase of the FIKK family that modifies the placental cytoadhesion machinery of P. falciparum-infected erythrocytes (PMID:42525717). FIKK1 directly phosphorylates the PfEMP1 variant adhesin VAR2CSA in vitro, targeting several residues in the DBL1-3 domains including S429 and T934, and this phosphorylation increases binding of recombinant VAR2CSA to the placental receptor chondroitin sulphate A (CSA) (PMID:42525717). Within infected erythrocytes FIKK1 localizes to punctate foci in Maurer's clefts where it co-localizes with VAR2CSA, placing the kinase and its substrate in the same trafficking compartment (PMID:42525717). Conditional knockout of FIKK1 reduces infected-erythrocyte cytoadhesion to CSA without changing VAR2CSA surface abundance, establishing that FIKK1 activity — rather than adhesin display — is required for full placental cytoadhesion (PMID:42525717). Beyond this phosphorylation-dependent regulation of VAR2CSA-mediated CSA adhesion, no further mechanistic detail for PF3D7_0102600 has been characterized in the available corpus.

1. 2026 High

   It was unknown whether a specific FIKK-family kinase directly modifies VAR2CSA; the in vitro kinase assay showed FIKK1 phosphorylates VAR2CSA DBL1-3 at defined residues and that this modification enhances CSA binding, establishing FIKK1 as a direct regulator of adhesin receptor engagement.

   Evidence In vitro phosphorylation assay with recombinant FIKK1 and VAR2CSA plus site-specific phosphosite mapping and CSA-binding readout

   PMID:42525717

   Open questions at the time

   • Whether S429/T934 phosphorylation is sufficient versus one of several required modifications is not resolved
   • The structural basis for how phosphorylation increases CSA affinity is not defined
   • In vitro phosphorylation may not fully reflect stoichiometry or kinetics in the parasite
2. 2026 Medium

   The subcellular site of FIKK1 action was undefined; tagged-protein imaging placed FIKK1 in punctate Maurer's cleft foci co-localizing with VAR2CSA, providing the spatial context in which the kinase and substrate meet.

   Evidence Immunofluorescence of HA-tagged FIKK1 in an inducible transgenic P. falciparum line

   PMID:42525717

   Open questions at the time

   • Single-method localization without orthogonal fractionation or reciprocal co-IP
   • Whether co-localization reflects direct physical interaction at Maurer's clefts is not shown
   • The trafficking route bringing FIKK1 to the clefts is uncharacterized
3. 2026 High

   Whether FIKK1 activity is functionally required for cytoadhesion, rather than merely biochemically capable of phosphorylating VAR2CSA, was untested; conditional knockout reduced CSA cytoadhesion while leaving VAR2CSA surface levels intact, establishing a phosphorylation-dependent (not display-dependent) role in placental adhesion.

   Evidence Rapamycin-inducible conditional knockout of FIKK1 followed by CSA cytoadhesion assay

   PMID:42525717

   Open questions at the time

   • Residual cytoadhesion in the knockout implies additional contributing factors not identified
   • Direct demonstration that the adhesion defect is caused by loss of VAR2CSA phosphorylation in vivo is not shown
   • In vivo relevance to placental sequestration and pathology not tested

• It remains unknown whether FIKK1 has substrates beyond VAR2CSA, how its kinase activity is regulated, and whether its adhesion role generalizes beyond CSA-mediated placental cytoadhesion.
• No substrate repertoire beyond VAR2CSA established
• No regulatory or activation mechanism for the kinase characterized
• No structural model of FIKK1 or its substrate complex